A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways

α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease

(2015) Byung-Wook Kim et al.   NEUROPHARMACOLOGY

Microglial dysfunction in brain aging and Alzheimer's disease

(2014) Kira Irving Mosher et al.   BIOCHEMICAL PHARMACOLOGY

Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis

(2014) S. Saravanan et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK

(2013) Morgana Rodrigues Guimarães et al.   ARCHIVES OF ORAL BIOLOGY

Strategic Selection of Neuroinflammatory Models in Parkinson's Disease: Evidence from Experimental Studies

(2013) Sandeep More et al.   CNS & Neurological Disorders-Drug Targets

Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-κB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells

(2013) Sandeep Vasant More et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Neuroinflammation: The role and consequences

(2013) Monty Lyman et al.   NEUROSCIENCE RESEARCH

Regulation of Microglia Activity by Glaucocalyxin-A: Attenuation of Lipopolysaccharide-Stimulated Neuroinflammation through NF-κB and p38 MAPK Signaling Pathways

(2013) Byung-Wook Kim et al.   PLoS One

Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS

(2012) Bing Liao et al.   EXPERIMENTAL NEUROLOGY

Hemokinin-1 Gene Expression Is Upregulated in Microglia Activated by Lipopolysaccharide through NF-κB and p38 MAPK Signaling Pathways

(2012) Atsushi Sakai et al.   PLoS One

The role of neuroinflammation on the pathogenesis of Parkinson's disease

(2011) Young-Cheul Chung et al.   BMB Reports

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

(2011) Yvonne Couch et al.   Journal of Neuroinflammation

Pathological roles of MAPK signaling pathways in human diseases

(2010) Eun Kyung Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Inflexin attenuates proinflammatory responses and nuclear factor-κB activation in LPS-treated microglia

(2010) Hyun Myung Ko et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia

(2010) Dah-Yuu Lu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Microglia in neurodegenerative disease

(2010) V. Hugh Perry et al.   Nature Reviews Neurology

Synthesis and nuclear factor-κB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamides

(2009) Jae-Hwan Kwak et al.   ARCHIVES OF PHARMACAL RESEARCH

Blockade of IL-15 activity inhibits microglial activation through the NFκB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release

(2009) Diego Gomez-Nicola et al.   GLIA

Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway

(2008) Bao-Wei Wang et al.   JOURNAL OF ENDOCRINOLOGY